Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

HLA-A*24:02 (Monomer) protein (MAGE-A3)

Origin: Human Host: HEK-293 Cells Recombinant > 95 % as determined by Tris-Bis PAGE,> 95 % as determined by HPLC
Catalog No. ABIN7454319
  • Target
    HLA-A*24:02
    Protein Type
    Recombinant
    Protein Characteristics
    Monomer
    Origin
    Human
    Source
    • 9
    • 1
    HEK-293 Cells
    Purification tag / Conjugate
    MAGE-A3
    Purpose
    Human HLA-A*24:02 & B2M & MAGE-A3 (IMPKAGLLI) Monomer Protein
    Sequence
    Gly25-Thr305 (HLA-A*24:02), Ile21-Met119 (B2M) and IMPKAGLLI peptide
    Specificity
    Uni-Prot: AAA59600.1 (HLA-A*24:02), P61769 (B2M), IMPKAGLLI
    Characteristics
    Recombinant Human MAGE-A3(HLA-A*24:02) Protein is expressed from HEK293 with His tag and Avi tag at the C-Terminus.It contains Gly25-Thr305(HLA-A*24:02), Ile21-Met119(B2M) and IMPKAGLLI peptide.
    Purity
    > 95 % as determined by Tris-Bis PAGE,> 95 % as determined by HPLC
    Sterility
    0.22 μm filtered
    Endotoxin Level
    Less than 1EU per μg by the LAL method.
  • Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/mL is recommended. Dissolve the lyophilized protein in distilled water.
    Buffer
    Lyophilized from 0.22μm filtered solution in PBS ( pH 7.4). Normally 8 % trehalose is added as protectant before lyophilization.
    Storage
    -20 °C,-80 °C
    Storage Comment
    -20 to -80°C for 12 months as supplied from date of receipt.,-80°C for 3-6 months after reconstitution.,2-8°C for 2-7 days after reconstitution.,Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
    Expiry Date
    12 months
  • Target
    HLA-A*24:02
    Background
    Melanoma antigen gene A3 (MAGE-A3) is one of the most immunogenic cancer testis antigens and is common in various types of cancers. MAGE-A3 can be considered as a predictor for poor prognosis and an option for vaccine immunotherapy in patients with PCa.
    Molecular Weight
    50.20 kDa. Due to glycosylation, the protein migrates to 55-60 kDa based on Tris-Bis PAGE result.
You are here: